Loading [MathJax]/jax/output/HTML-CSS/fonts/TeX/fontdata.js

Journal List > Korean J Gastroenterol > v.63(2) > 1007257

Jo: Decreased Eradication Rates of Helicobacter pylori and Problem Solving

Abstract

Article

Trends in the Eradication Rates of Helicobacter pylori Infection in Daegu and Gyeongsangbuk-do, Korea: Multicenter Study over 13 Years

Go to : Goto

References

1. Kim SG, Jung HK, Lee HL, et al. Korean College of Helicobacter and Upper Gastrointestinal Research. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol. 2013; 62:3–26.
2. Choi YS, Cheon JH, Lee JY, et al. The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years. Korean J Gastroenterol. 2006; 48:156–161.
3. Na HS, Hong SJ, Yoon HJ, et al. Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and re-infection rate after successful eradication. Korean J Gastroenterol. 2007; 50:170–175.
4. Cho HJ, Bae RC, Lee SH, et al. The trend in the eradication rates of first- and second-line therapy for Helicobacter pylori infection in Daegu and Kyungpook provinces: a single center experience for the most recent 9 years. Korean J Med. 2009; 76:186–192.
5. Cho DK, Park SY, Kee WJ, et al. The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy. Korean J Gastroenterol. 2010; 55:368–375.
6. Chung JW, Lee GH, Han JH, et al. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. Hepatogastroenterology. 2011; 58:246–250.
7. Yoon JH, Baik GH, Sohn KM, et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. World J Gastroenterol. 2012; 18:6628–6634.
8. Jung YS, Lee SH, Park CS, et al. Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk- do, Korea: multicenter study over 13 years. Korean J Gastroenterol. 2014; 63:82–89.
9. Sasaki H, Nagahara A, Hojo M, et al. Ten-year trend of the cumulative Helicobacter pylori eradication rate for the ‘Japanese eradication strategy’. Digestion. 2013; 88:272–278.
10. Ang TL, Wang L, Ang D, Chiam P, Fock KM, Teo EK. Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis. J Dig Dis. 2013; 14:100–104.
11. Lee JW, Kim N, Kim JM, et al. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter. 2013; 18:206–214.
12. Byun YH, Jo YJ, Kim SC, et al. Clinical factors that predicts successful eradication of Helicobacter pylori. Korean J Gastroenterol. 2006; 48:172–179.
13. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010; 59:1143–1153.
14. Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013; 12:CD008337.
Go to : Goto

Table 1.
Trend in Eradication Rate of Helicobacter pylori in Korea and Asia
Published year Trend in eradication rate Period of study Patient (n) Regimens/duration (day) Overall rat (%) Province
20062 Not decreased 1998-2005 525 PAC/7 78.7 Seoul (Korea)
20073 Not decreased 2001-2006 3,267 PAC/7 84.3 Gyeonggi (Korea)
  Not decreased 2001-2006 317 PBMT/7 86.7  
20094 Not decreased 1999-2007 615 PAC/7 81.6 Daegu, Gyeongbuk (Korea)
20105 Not decreased 2001-2009 709 PAC/7 77.0 Gwangju, Chonnam (Korea)
20116 Decreased 2001-2007 4,198 PAC/7 80.1 Seoul (Korea)
  Not decreased 2001-2007 490 PBMT/7 87.7  
20127 Not decreased 2000-2010 3,969 PAC/14 86.5 Gangwon (Korea)
    2000-2010 399 PBMT/7 84.7  
20148 Not decreased 1999-2011 2,630 PAC/7 87.1 Daegu, Gyeongbuk (Korea)
    1999-2011 239 PBMT/7 88.3  
20139 Decreased 2000-2009 1,973 PAC/7 70.8 Japan
  Not decreased 2000-2009 250 PAM/7 86.8  
201310 Not decreased 2005-2010 465 PAC/7 89.5 Singapore

PAC, proton pump inhibitor+ amoxicillin+ clarithromycin; PBMT, proton pump inhibitor+ bisthmus+ metronidazole+ tetracycline; PAM, proton pump inhibitor+ amoxicillin+ metronidazole.

TOOLS
Similar articles